10:04 AM EST - Ondine Biopharma Corp. : has reported a third-quarter loss of $3.2 million as it continued developing its medical and dental photo-disinfection technology. The July-September loss reported Tuesday, worth six cents per share, compared with a year-earlier loss of $2.8 million, also six cents per share. Ondine Biopharma Corp.
shares T.OBP are trading down 10 cents at $1.20.
